Furthermore, FOXO‐1 mRNA is a validated target of miR‐196a in cervical cancer, hepatocellular carcinoma, and lung cancer [17, 18, 19], and inhibits EMT in hepatocellular carcinoma [20]. Here, FOXO1 is linked to lung cancer.